Trypzean™: An animal-free alternative to bovine trypsin

6Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Trypsin derived from either porcine or bovine pancreas is widely used in biopharmaceutical manufacturing. This industry is working toward replacing animal source materials with alternatives to prevent contamination of the products with mammalian viruses and human pathogens. Bovine trypsin made in maize seed culminated in a commercial product, TrypZean™, which is a possible replacement product for use in cell culture and viral vaccine manufacturing, as well as in the processing of therapeutic proteins. This chapter describes the development of this product from a plant biotechnology perspective and then discusses how it is being used today. Possible improvements to make this product more cost competitive are discussed.

Cite

CITATION STYLE

APA

Krishnan, A., & Woodard, S. L. (2014). TrypzeanTM: An animal-free alternative to bovine trypsin. In Biotechnology in Agriculture and Forestry (Vol. 68, pp. 43–63). Springer International Publishing. https://doi.org/10.1007/978-3-662-43836-7_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free